OREANDA-NEWS. February 21, 2013. China Kanghui Holdings (China Kanghui) is a holding company. It develops, manufactures and markets orthopedic implants in China.

The company's product portfolio consist of around 36 product series of orthopedic implants and related instruments for spine and trauma indications. Its trauma products include nails, plates and screws, cranial facial plate and screw systems, which are used in the surgical treatment of bone fractures.

The spine products include screws, meshes, inter body cages and fixation systems, which are used in the surgical treatment of spine disorders. It markets under through two brands, namely, Kanghui and Libeier across Asia, Europe, Africa, South America and Australia. The company operates through Changzhou Kanghui Medical Innovation Co., Ltd. China Kanghui is headquartered in Changzhou, Jiangsu, China.

The company streamlines its research efforts with corporate development activities with an intend to expand product portfolio as recently it invested USD 4m in Consensus Orthopedics.

This report is a source for data, analysis and actionable intelligence on the China Kanghui Holdings portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.